nodes	percent_of_prediction	percent_of_DWPC	metapath
Cocaine—CYP2C8—Levothyroxine—hypothyroidism	0.268	0.42	CbGbCtD
Cocaine—CYP2C8—Liotrix—hypothyroidism	0.262	0.41	CbGbCtD
Cocaine—CYP3A4—Levothyroxine—hypothyroidism	0.109	0.17	CbGbCtD
Cocaine—SCN11A—nerve—hypothyroidism	0.0283	0.166	CbGeAlD
Cocaine—SCN10A—nerve—hypothyroidism	0.0143	0.084	CbGeAlD
Cocaine—Ulcer—Liotrix—hypothyroidism	0.0111	0.127	CcSEcCtD
Cocaine—SLC6A3—nerve—hypothyroidism	0.0111	0.0648	CbGeAlD
Cocaine—CYP2C9—urine—hypothyroidism	0.00943	0.0553	CbGeAlD
Cocaine—SLC6A2—nerve—hypothyroidism	0.00892	0.0523	CbGeAlD
Cocaine—CYP3A4—urine—hypothyroidism	0.00719	0.0422	CbGeAlD
Cocaine—CYP2D6—urine—hypothyroidism	0.00707	0.0415	CbGeAlD
Cocaine—Tension—Dextrothyroxine—hypothyroidism	0.00612	0.0698	CcSEcCtD
Cocaine—Tension—Levothyroxine—hypothyroidism	0.00612	0.0698	CcSEcCtD
Cocaine—Nervousness—Dextrothyroxine—hypothyroidism	0.00606	0.0691	CcSEcCtD
Cocaine—Nervousness—Levothyroxine—hypothyroidism	0.00606	0.0691	CcSEcCtD
Cocaine—Tremor—Dextrothyroxine—hypothyroidism	0.00585	0.0666	CcSEcCtD
Cocaine—Tremor—Levothyroxine—hypothyroidism	0.00585	0.0666	CcSEcCtD
Cocaine—Agitation—Levothyroxine—hypothyroidism	0.00574	0.0654	CcSEcCtD
Cocaine—Agitation—Dextrothyroxine—hypothyroidism	0.00574	0.0654	CcSEcCtD
Cocaine—SLC6A4—Monoamine Transport—SLC5A7—hypothyroidism	0.00554	0.0538	CbGpPWpGaD
Cocaine—SLC6A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00502	0.0487	CbGpPWpGaD
Cocaine—SCN5A—heart—hypothyroidism	0.00483	0.0284	CbGeAlD
Cocaine—SLC6A2—Monoamine Transport—SLC5A7—hypothyroidism	0.00477	0.0462	CbGpPWpGaD
Cocaine—SCN5A—cardiovascular system—hypothyroidism	0.00456	0.0268	CbGeAlD
Cocaine—Tension—Liotrix—hypothyroidism	0.0045	0.0513	CcSEcCtD
Cocaine—Nervousness—Liotrix—hypothyroidism	0.00446	0.0508	CcSEcCtD
Cocaine—SLC6A3—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00445	0.0431	CbGpPWpGaD
Cocaine—SCN10A—pituitary gland—hypothyroidism	0.00444	0.0261	CbGeAlD
Cocaine—Tremor—Liotrix—hypothyroidism	0.0043	0.049	CcSEcCtD
Cocaine—SLC6A3—Monoamine Transport—SLC5A7—hypothyroidism	0.00422	0.041	CbGpPWpGaD
Cocaine—Agitation—Liotrix—hypothyroidism	0.00422	0.0481	CcSEcCtD
Cocaine—CHRM2—heart—hypothyroidism	0.00412	0.0241	CbGeAlD
Cocaine—CYP3A7—liver—hypothyroidism	0.00407	0.0239	CbGeAlD
Cocaine—SLC22A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00405	0.0392	CbGpPWpGaD
Cocaine—SCN10A—blood—hypothyroidism	0.00397	0.0233	CbGeAlD
Cocaine—CHRM2—cardiovascular system—hypothyroidism	0.00388	0.0228	CbGeAlD
Cocaine—SCN5A—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.00371	0.036	CbGpPWpGaD
Cocaine—SCN5A—blood—hypothyroidism	0.00361	0.0212	CbGeAlD
Cocaine—CHRM1—cardiovascular system—hypothyroidism	0.00353	0.0207	CbGeAlD
Cocaine—CYP3A7-CYP3A51P—liver—hypothyroidism	0.00346	0.0203	CbGeAlD
Cocaine—Vomiting—Dextrothyroxine—hypothyroidism	0.00324	0.0369	CcSEcCtD
Cocaine—Vomiting—Levothyroxine—hypothyroidism	0.00324	0.0369	CcSEcCtD
Cocaine—SLC22A2—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00309	0.03	CbGpPWpGaD
Cocaine—SLC6A2—gonad—hypothyroidism	0.00284	0.0166	CbGeAlD
Cocaine—SLC6A4—blood—hypothyroidism	0.00281	0.0165	CbGeAlD
Cocaine—Hypersensitivity—Liotrix—hypothyroidism	0.00276	0.0315	CcSEcCtD
Cocaine—SLC6A4—Synaptic Vesicle Pathway—CLTC—hypothyroidism	0.00265	0.0257	CbGpPWpGaD
Cocaine—SLC6A3—testis—hypothyroidism	0.00253	0.0149	CbGeAlD
Cocaine—SLC6A2—adrenal gland—hypothyroidism	0.00247	0.0145	CbGeAlD
Cocaine—CYP2C9—heart—hypothyroidism	0.00242	0.0142	CbGeAlD
Cocaine—Vomiting—Liotrix—hypothyroidism	0.00238	0.0272	CcSEcCtD
Cocaine—SLC6A3—cerebellum—hypothyroidism	0.00234	0.0137	CbGeAlD
Cocaine—CYP2C9—cardiovascular system—hypothyroidism	0.00228	0.0134	CbGeAlD
Cocaine—CYP2C8—pituitary gland—hypothyroidism	0.00227	0.0133	CbGeAlD
Cocaine—SCN5A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00219	0.0213	CbGpPWpGaD
Cocaine—SLC6A2—testis—hypothyroidism	0.00204	0.012	CbGeAlD
Cocaine—CYP2C8—blood—hypothyroidism	0.00203	0.0119	CbGeAlD
Cocaine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00196	0.019	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00191	0.0186	CbGpPWpGaD
Cocaine—CYP3A5—blood—hypothyroidism	0.00183	0.0107	CbGeAlD
Cocaine—CYP2C9—blood—hypothyroidism	0.0018	0.0106	CbGeAlD
Cocaine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00174	0.0169	CbGpPWpGaD
Cocaine—CYP3A5—female gonad—hypothyroidism	0.00171	0.01	CbGeAlD
Cocaine—CYP2C8—testis—hypothyroidism	0.00168	0.00985	CbGeAlD
Cocaine—SLC6A4—NRF2 pathway—SLC5A7—hypothyroidism	0.00165	0.016	CbGpPWpGaD
Cocaine—CYP2C8—liver—hypothyroidism	0.00159	0.00931	CbGeAlD
Cocaine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00158	0.0153	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—CLTC—hypothyroidism	0.0015	0.0145	CbGpPWpGaD
Cocaine—CYP3A5—liver—hypothyroidism	0.00143	0.0084	CbGeAlD
Cocaine—SLC6A2—NRF2 pathway—SLC5A7—hypothyroidism	0.00142	0.0137	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00141	0.0137	CbGpPWpGaD
Cocaine—CYP2C9—liver—hypothyroidism	0.00141	0.00827	CbGeAlD
Cocaine—CYP3A4—blood—hypothyroidism	0.00137	0.00806	CbGeAlD
Cocaine—CYP2D6—blood—hypothyroidism	0.00135	0.00793	CbGeAlD
Cocaine—CYP2D6—female gonad—hypothyroidism	0.00126	0.0074	CbGeAlD
Cocaine—SLC6A3—NRF2 pathway—SLC5A7—hypothyroidism	0.00125	0.0122	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00123	0.012	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00113	0.011	CbGpPWpGaD
Cocaine—CYP2D6—testis—hypothyroidism	0.00112	0.00656	CbGeAlD
Cocaine—CYP3A4—liver—hypothyroidism	0.00107	0.0063	CbGeAlD
Cocaine—SCN11A—Developmental Biology—CLTC—hypothyroidism	0.00107	0.0104	CbGpPWpGaD
Cocaine—CYP2D6—liver—hypothyroidism	0.00106	0.0062	CbGeAlD
Cocaine—SLC6A4—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00106	0.0102	CbGpPWpGaD
Cocaine—CYP2D6—cerebellum—hypothyroidism	0.00103	0.00606	CbGeAlD
Cocaine—SCN10A—Axon guidance—CLTC—hypothyroidism	0.000983	0.00953	CbGpPWpGaD
Cocaine—SLC6A3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000975	0.00945	CbGpPWpGaD
Cocaine—SLC6A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000892	0.00865	CbGpPWpGaD
Cocaine—SLC22A2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000887	0.0086	CbGpPWpGaD
Cocaine—SCN5A—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.000853	0.00828	CbGpPWpGaD
Cocaine—SLC6A3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00079	0.00766	CbGpPWpGaD
Cocaine—SLC6A3—Neuronal System—SLC5A7—hypothyroidism	0.000747	0.00724	CbGpPWpGaD
Cocaine—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000739	0.00717	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000729	0.00707	CbGpPWpGaD
Cocaine—SLC22A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000719	0.00697	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—VAV3—hypothyroidism	0.000706	0.00685	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—CLTC—hypothyroidism	0.000701	0.0068	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—CLTC—hypothyroidism	0.000691	0.0067	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—SLC5A7—hypothyroidism	0.00068	0.00659	CbGpPWpGaD
Cocaine—SLC6A4—NRF2 pathway—SLC5A5—hypothyroidism	0.000658	0.00638	CbGpPWpGaD
Cocaine—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000655	0.00635	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000632	0.00613	CbGpPWpGaD
Cocaine—SLC6A3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000628	0.00609	CbGpPWpGaD
Cocaine—SLC22A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000596	0.00578	CbGpPWpGaD
Cocaine—SLC22A2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000571	0.00554	CbGpPWpGaD
Cocaine—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.000566	0.00549	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000563	0.00546	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—VAV3—hypothyroidism	0.000504	0.00489	CbGpPWpGaD
Cocaine—SLC6A3—NRF2 pathway—SLC5A5—hypothyroidism	0.000501	0.00486	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—CLTC—hypothyroidism	0.000493	0.00478	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000491	0.00476	CbGpPWpGaD
Cocaine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000487	0.00472	CbGpPWpGaD
Cocaine—CHRM1—G alpha (q) signalling events—TRH—hypothyroidism	0.000484	0.0047	CbGpPWpGaD
Cocaine—SLC6A3—Neuronal System—NEFL—hypothyroidism	0.000481	0.00467	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—VAV3—hypothyroidism	0.000463	0.00449	CbGpPWpGaD
Cocaine—CHRM1—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000461	0.00448	CbGpPWpGaD
Cocaine—CHRM2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000455	0.00442	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000453	0.0044	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—NEFL—hypothyroidism	0.000438	0.00425	CbGpPWpGaD
Cocaine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000433	0.0042	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000402	0.00389	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—AVP—hypothyroidism	0.000401	0.00389	CbGpPWpGaD
Cocaine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000395	0.00383	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000376	0.00364	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000365	0.00354	CbGpPWpGaD
Cocaine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000357	0.00346	CbGpPWpGaD
Cocaine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000352	0.00341	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000333	0.00323	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—VAV3—hypothyroidism	0.00033	0.00321	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—VAV3—hypothyroidism	0.000326	0.00316	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000321	0.00311	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000317	0.00307	CbGpPWpGaD
Cocaine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000316	0.00306	CbGpPWpGaD
Cocaine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000305	0.00296	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000303	0.00294	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00029	0.00282	CbGpPWpGaD
Cocaine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000287	0.00279	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000286	0.00277	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000286	0.00277	CbGpPWpGaD
Cocaine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000285	0.00277	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000282	0.00274	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000282	0.00274	CbGpPWpGaD
Cocaine—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000281	0.00272	CbGpPWpGaD
Cocaine—CHRM1—G alpha (q) signalling events—AVP—hypothyroidism	0.000254	0.00247	CbGpPWpGaD
Cocaine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00025	0.00243	CbGpPWpGaD
Cocaine—SLC6A3—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000249	0.00241	CbGpPWpGaD
Cocaine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000248	0.00241	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—IYD—hypothyroidism	0.000247	0.0024	CbGpPWpGaD
Cocaine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000247	0.0024	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—IYD—hypothyroidism	0.000247	0.00239	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—TRH—hypothyroidism	0.000244	0.00237	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—TRH—hypothyroidism	0.000241	0.00234	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—AVP—hypothyroidism	0.00024	0.00233	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—VAV3—hypothyroidism	0.000232	0.00225	CbGpPWpGaD
Cocaine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000228	0.00221	CbGpPWpGaD
Cocaine—SLC22A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000226	0.00219	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—TSHR—hypothyroidism	0.000218	0.00211	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—TSHB—hypothyroidism	0.000218	0.00211	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—TSHB—hypothyroidism	0.000215	0.00208	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—TSHR—hypothyroidism	0.000215	0.00208	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—ATP5O—hypothyroidism	0.00021	0.00204	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—ATP5O—hypothyroidism	0.00021	0.00204	CbGpPWpGaD
Cocaine—CYP3A7—Biological oxidations—POMC—hypothyroidism	0.00021	0.00203	CbGpPWpGaD
Cocaine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000203	0.00197	CbGpPWpGaD
Cocaine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000201	0.00195	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—TPO—hypothyroidism	0.000198	0.00192	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—TPO—hypothyroidism	0.000197	0.00191	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000181	0.00176	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—IYD—hypothyroidism	0.000179	0.00173	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000168	0.00163	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000166	0.00161	CbGpPWpGaD
Cocaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000164	0.00159	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00016	0.00156	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—IYD—hypothyroidism	0.000155	0.0015	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—ATP5O—hypothyroidism	0.000152	0.00147	CbGpPWpGaD
Cocaine—CYP3A5—Biological oxidations—POMC—hypothyroidism	0.000151	0.00147	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000146	0.00142	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—TPO—hypothyroidism	0.000143	0.00139	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000143	0.00138	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—POMC—hypothyroidism	0.000139	0.00135	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—TRH—hypothyroidism	0.000138	0.00134	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	0.000136	0.00132	CbGpPWpGaD
Cocaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000133	0.00129	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—ATP5O—hypothyroidism	0.000132	0.00128	CbGpPWpGaD
Cocaine—CYP2C8—Biological oxidations—POMC—hypothyroidism	0.000131	0.00127	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—AVP—hypothyroidism	0.000128	0.00124	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—IYD—hypothyroidism	0.000127	0.00123	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—AVP—hypothyroidism	0.000127	0.00123	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000126	0.00123	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—IYD—hypothyroidism	0.000126	0.00122	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—TRH—hypothyroidism	0.000125	0.00122	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—TPO—hypothyroidism	0.000124	0.0012	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—TRH—hypothyroidism	0.000124	0.0012	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—TSHR—hypothyroidism	0.000123	0.00119	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—TSHB—hypothyroidism	0.000123	0.00119	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	0.000121	0.00118	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	0.000121	0.00118	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000115	0.00112	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000115	0.00111	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000112	0.00109	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—TSHB—hypothyroidism	0.000112	0.00108	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—TSHR—hypothyroidism	0.000112	0.00108	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000111	0.00107	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	0.00011	0.00107	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	0.00011	0.00107	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000108	0.00105	CbGpPWpGaD
Cocaine—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000108	0.00104	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—ATP5O—hypothyroidism	0.000107	0.00104	CbGpPWpGaD
Cocaine—CYP2C9—Biological oxidations—POMC—hypothyroidism	0.000107	0.00104	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—TPO—hypothyroidism	0.000102	0.000986	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—TPO—hypothyroidism	0.000101	0.000977	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.33e-05	0.000905	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—TSHB—hypothyroidism	9.15e-05	0.000888	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—TSHB—hypothyroidism	9.14e-05	0.000886	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—CLTC—hypothyroidism	8.57e-05	0.000831	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—POMC—hypothyroidism	8.53e-05	0.000827	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—CLTC—hypothyroidism	8.46e-05	0.00082	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—POMC—hypothyroidism	8.42e-05	0.000816	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—IYD—hypothyroidism	8.31e-05	0.000806	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	8.16e-05	0.000791	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	8.14e-05	0.00079	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—VAV3—hypothyroidism	7.52e-05	0.00073	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	7.43e-05	0.000721	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—TRH—hypothyroidism	7.4e-05	0.000718	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—TRH—hypothyroidism	7.31e-05	0.000709	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—AVP—hypothyroidism	7.25e-05	0.000703	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	7.16e-05	0.000694	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—ATP5O—hypothyroidism	7.07e-05	0.000685	CbGpPWpGaD
Cocaine—CYP3A4—Biological oxidations—POMC—hypothyroidism	7.04e-05	0.000683	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—SLC5A5—hypothyroidism	6.85e-05	0.000665	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—SLC5A5—hypothyroidism	6.84e-05	0.000663	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	6.83e-05	0.000663	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	6.75e-05	0.000654	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—TPO—hypothyroidism	6.64e-05	0.000644	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—TSHB—hypothyroidism	6.61e-05	0.000642	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—TSHB—hypothyroidism	6.6e-05	0.00064	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—TSHR—hypothyroidism	6.6e-05	0.00064	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—AVP—hypothyroidism	6.58e-05	0.000639	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—TSHB—hypothyroidism	6.51e-05	0.000632	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—TSHR—hypothyroidism	6.51e-05	0.000632	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—AVP—hypothyroidism	6.5e-05	0.00063	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	5.9e-05	0.000572	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	5.88e-05	0.000571	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	5.81e-05	0.000563	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—TSHB—hypothyroidism	5.73e-05	0.000556	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	5.11e-05	0.000495	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.04e-05	0.000489	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—SLC5A5—hypothyroidism	4.95e-05	0.00048	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	4.82e-05	0.000467	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	4.76e-05	0.000461	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—TSHB—hypothyroidism	4.7e-05	0.000456	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—TSHB—hypothyroidism	4.66e-05	0.000452	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—POMC—hypothyroidism	4.37e-05	0.000424	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—PRL—hypothyroidism	4.36e-05	0.000423	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—POMC—hypothyroidism	4.32e-05	0.000419	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—PRL—hypothyroidism	4.31e-05	0.000418	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—SLC5A5—hypothyroidism	4.29e-05	0.000416	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	4.19e-05	0.000407	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	4.16e-05	0.000403	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.1e-05	0.000398	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—VAV3—hypothyroidism	4.04e-05	0.000392	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—VAV3—hypothyroidism	3.98e-05	0.000387	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—AVP—hypothyroidism	3.89e-05	0.000377	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—AVP—hypothyroidism	3.84e-05	0.000372	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—POMC—hypothyroidism	3.58e-05	0.000348	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—POMC—hypothyroidism	3.58e-05	0.000347	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.52e-05	0.000342	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—SLC5A5—hypothyroidism	3.49e-05	0.000339	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—TSHB—hypothyroidism	3.08e-05	0.000298	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.74e-05	0.000266	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—POMC—hypothyroidism	2.59e-05	0.000251	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—POMC—hypothyroidism	2.58e-05	0.000251	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—POMC—hypothyroidism	2.55e-05	0.000247	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—IGF1—hypothyroidism	2.49e-05	0.000241	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—IGF1—hypothyroidism	2.45e-05	0.000238	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.3e-05	0.000223	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—POMC—hypothyroidism	2.24e-05	0.000218	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—POMC—hypothyroidism	1.84e-05	0.000179	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—POMC—hypothyroidism	1.83e-05	0.000177	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—POMC—hypothyroidism	1.2e-05	0.000117	CbGpPWpGaD
